Article Information
History
- December 21, 2022.
Article Versions
- You are currently viewing Version 1 of this article (December 21, 2022 - 14:25).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sierra S. Nishizaki1,2,3,4,
- Natasha Ann F. Mariano1,5,
- Gabriana N. La1,
- José M. Uribe-Salazar1,6,
- Gulhan Kaya1,
- Derek Sayre Andrews3,4,
- Christine Wu Nordahl3,4,
- David G. Amaral3,4 and
- Megan Y. Dennis1,3,4,6,†
- 1Genome Center, University of California Davis, CA, USA
- 2Autism Research Training Program, University of California Davis, CA, USA
- 3Department of Psychiatry and Behavioral Sciences, University of California Davis, CA, USA
- 4MIND Institute, University of California Davis, CA, USA
- 5Postbaccalaureate Research Education Program, University of California Davis, CA, USA
- 6Department of Biochemistry & Molecular Medicine, University of California Davis, CA, USA
- ↵†Corresponding author: Megan Y. Dennis, Ph.D., University of California, Davis, School of Medicine, One Shields Avenue, Genome Center, 4303 GBSF, Davis, CA 95616, Email: mydennis{at}ucdavis.edu
Posted December 21, 2022.
A Subphenotype-to-Genotype Approach Reveals Disproportionate Megalencephaly Autism Risk Genes
